Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IIa randomized observer-blind trial of Tyrosur Gel for promotion of superficial wound healing
2010-020809-33Phase 2Completed
- Sponsor
- Engelhard Arzneimittel
- Start
- Aug 2010
- Modality
- Small Molecules, Recombinant Proteins and Enzymes, Hydrogel Systems → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial of Tyrosur in Abnormal wound healing and cutaneous wound (3 arms), sponsored by Engelhard Arzneimittel. Primary endpoint: Primary wound healing efficacy endpoint. Started Aug 2010; status: completed.
02
Drugs
Tyrosur
03
Conditions
Abnormal wound healingcutaneous wound
Beyond the preview
Go deeper on 2010-020809-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-020809-33.